Abstract
The periodic paralyses are characterized by episodic attacks of paralysis. They are usually classified as primary (familial) or secondary and, according to the associated change in serum potassium, as hypokalemic, hyperkalemic, or normokalemic. The pattern of electrolyte changes is usually similar from attack to attack in a given patient; however, rarely, a single patient will have paralysis associated with an elevated, depressed, or unchanged serum K+ concentration.(1) The different forms of periodic paralysis share several features: (1) the attacks may last from minutes to days and occur sporadically, (2) the paralysis can be focal or generalized, (3) the tendon reflexes are depressed, (4) respiratory and cranial nerve-innervated muscles are relatively spared, (5) rest after exercise can provoke an attack whereas continuous activity can allay paresis, (6) cooling of muscles may produce weakness, (7) whereas early in the course of the disease the patient may have normal strength between attacks, progressive proximal weakness can develop after repeated attacks in the primary forms of periodic paralysis.(2)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chesson, A. L., S. S. Schochet, and B. H. Peter. 1979. Biphasic periodic paralysis. Arch. Neurol. 36: 700–704.
Pearson, C. M. 1964. The periodic paralysis: Differential features and pathological observations in permanent myopathic weakness. Brain 87: 341–358.
Hartwig, H. 1875. Ober emien fall von intermittiereuder paralysis spinalis. Zentralbi. Med. Wiss. 13: 428.
Endo, M. 1977. Calcium release from the sarcoplasmic reticulum. Physiol. Rev. 57: 71–102.
Johnsen, T. 1981. Familial periodic paralysis with hypokalemia: Experimental and clinical investigations. Dan. Med. Bull. 28: 127.
Talbot, J. H. 1941. Periodic paralysis. Medicine (Baltimore) 20: 85–99.
Sagild, U. 1963. Hypoglycemia induced by potassium administration during attacks of periodic paralysis. Acta Med. Scand. 173: 329–332.
Engel, A. G. 1977. Hypokalemic and hyperkalemic periodic paralysis. In: Scientific Approach to Clinical Neurology. E. S. Goldensohn and S. H. Appel, eds. Lea & Febiger, Philadelphia. pp. 1742–1765.
Biermond, A., and A. P. Daniels. 1934. Familial periodic paralysis and its transition into spinal muscular atrophy. Brain 57: 91–109.
Allott, E. N., and B. McArdle. 1938. Further observations on familial periodic paralysis. Clin. Sci. Mol. Med. 3: 229–245.
Tones, C. F., R. C. Griggs, R. T. Moxley, and A. N. Bender. 1981. Hypokalemic periodic paralysis exacerbated by acetazolamide. Neurology (New York) 31: 1423–1428.
Van Buchem, F. S. P. 1957. The electrocardiogram and potassium metabolism. Am. J. Med. 23: 376–384.
Mathew, R., and P. S. Gupta. 1979. Periodic paralysis (report of six cases). J. Assoc. Physicians India 27: 663–667.
Wolf, P., J. Griffiths, J. Koett, and J. Howell. 1979. The presence of serum creatine kinase 2 (MB) in hypokalemic familial periodic paralysis. Enzyme 24: 197–199.
Resnick, J. S., and W. K. Engel. 1967. Myotonic lid lag in hypokalemic periodic paralysis. J. Neurol. Neurosurg. Psychiatry 30: 47–51.
McArdle, B. 1956. Familial periodic paralysis. Br. Med. Bull. 12: 226–229.
Shy, M., T. Wanko, P. T. Rowley, and A. G. Engel. 1961. Studies in familial periodic paralysis. Exp. Neurol. 3: 53–121.
Engel, A. G., E. H. Lambert, J. W. Rosevear, and W. N. Tauxe. 1965. Clinical and EMG studies in a patient with primary hypokalemic periodic paralysis. Am. J. Med. 38: 626–640.
Buruma, O. J. S., and G. T. A. M. Bots. 1978. Myopathy in familial hypokalemic periodic paralysis independent of paralytic attacks. Acta Neurol. Scand. 57: 171–179.
Buruma, O. J. S., J. J. Schipperheyn, and G. T. A. M. Bots. 1981. Heart muscle disease in familial hypokalemic periodic paralysis. Acta Neurol. Scand. 64: 12–21.
Chen, R. F. 1959. Familial periodic paralysis. Arch. Neurol. 1: 475–480.
Satoyoshi, E., K. Murakami, H. Kowa, M. Kinoshita, and Y. Mishiyama. 1963. Periodic paralysis in hyperthyroidism. Neurology (Minneapolis) 13: 746–752.
Engel, A. G. 1966. Electron microscopic observations in primary hypokalemic and thyrotoxic periodic paralysis. Mayo Clin. Proc. 41: 797–808.
Engel, A. G. 1961. Thyroid function and periodic paralysis. Am. J. Med. 30: 327–333.
Okihiro, M. M., and R. A. Nordyke. 1966. Hypokalemic periodic paralysis experimental precipitation with sodium lithyronine. J. Am. Med. Assoc. 198: 277–279.
Layzer, R. B., and E. Goldfield. 1974. Periodic paralysis caused by abuse of thyroid hormone. Neurology (Minneapolis) 24: 949–955.
Ober, K. P., and J. F. Hennessy. 1981. Jodbasedow and thyrotoxic periodic paralysis. Arch. Intern. Med. 141: 1225–1227.
Ruff, R. L. 1979. Insulin-induced weakness in hypokalemic myopathy. Ann. Neurol. 6: 139–140.
Conn, J. W. 1955. Presidential address. I. Painting background. II. Primary aldosteronism. J. Lab. Clin. Med. 45: 3–28.
Raskin, R. J., J. T. Tesan, and O. J. Lawless. 1981. Hypokalemic periodic paralysis in Sjogren’s syndrome. Arch. Intern. Med. 141: 1671–1673.
Milne, M. D., S. W. Stanbury, and A. E. Thompson. 1952. Observations on Fanconi syndrome and renal hyperchloremic acidosis in adults. Q. J. Med. 21: 61–74.
Bull, G. M., A. M. Joekes, and K. G. Lowe. 1950. Renal function studies in acute tubular necrosis. Clin. Sci. 9: 379–385.
Sataline, L. R., and J. M. Simonelli. 1961. Potassium paresis following ureterosignoidostomy. J. Urol. 85: 559–564.
Cohen, T. 1959. Hypokalemic muscle paralysis associated with administration of chlorothiazide. J. Am. Med. Assoc. 170: 2083–2086.
Salassa, R. M., V. R. Mattox, and J. W. Rosevear. 1962. Inhibition of the `mineralo-corticoid’ activity by licorice by spironolactone. J. Clin. Endocrinol. Metab. 22: 1156–1159.
Goulon, M., M. Rapin, J. Lissac, J. J. Pocidolo, and O. Mantel. 1962. Quadriplegia with hypokalemia and hypokalemic acidosis secondary to the absorption of ammonium chloride over a three-year period. Bull. Soc. Hop. Med. Paris 113: 113–115.
Keye, J. D. 1952. Death in potassium deficiency. Circulation 5: 766–769.
Keyloun, V. E., and W. J. Grace. 1967. Villous adenoma of the rectum associated with severe electrolyte imbalance. Am. J. Dig. Dis. 12: 104–108.
Verner, V. J., and A. B. Morrison. 1958. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am. J. Med. 25: 374–382.
Schwartz, W. B., and A. S. Relman. 1953. Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives. J. Clin. Invest. 32: 258–265.
Lewi, Z., and Y. Bar-Khayim. 1964. Food poisoning from barium carbonate. Lancet 2: 342–344.
Gamstorp, I., M. Hauge, H. F. Helweg-Larsen, H. Mjönes, and U. Sagild. 1957. Adynamia episodica hereditaria. Am. J. Med. 23: 385–390.
Armstrong, F. B. 1962. Hyperkalemic familial periodic paralysis. Ann. Intern. Med. 57: 455–461.
McArdle, B. 1962. Adynamia episodica hereditaria and its treatment. Brain 85: 121–148.
Layzer, R. B., R. E. Lovelace, and L. P. Rowland. 1967. Hyperkalemic periodic paralysis. Arch. Neurol. 16: 455.
Klein, R., and J. E. Haddow. 1970. Arterial-venous differences in serum potassium concentrations in paramyotonia. Pediatr. Res. 4: 286–294.
Thomas, C. 1978. Recent findings on the geneology, clinical aspects, and histology of a family with periodic hyperkalemic paralysis. Rev. Neurol. 134: 45–58.
Dyken, M. L., and G. D. Timmons. 1963. Hyperkalemic periodic paralysis with hypocalcemic episode. Arch. Neurol. 9: 508–517.
Riggs, J. E., R. T. Moxley, R. C. Griggs, and F. A. Homer. 1981. Hyperkalemic periodic paralysis: An apparent sporadic case. Neurology (New York) 31: 1157–1159.
Hudson, A. J., K. P. Strickland, and A. J. Wilensky. 1967. Serum enzyme studies in familial hyperkalemic periodic paralysis. Clin. Chim. Acta 17: 331–336.
Streeten, D. H. P., T. G. Dalakos, and H. Fellerman. 1971. Studies on hyperkalemic periodic paralysis: Evidence of changes in plasma Na and CI and induction of paralysis by adrenal glucocorticoids. J. Clin. Invest. 50: 142–155.
McDonald, R. D., N. B. Rewcastle, and J. G. Humphrey. 1968. The myopathy of hyperkalemic periodic paralysis. Arch. Neuol. 19: 274–279.
Carson, M. J., and C. M. Pearson. 1964. Familial hyperkalemic periodic paralysis with myotonic features. J. Pediatr. 64: 853–865.
Buchthal, F., L. Engback, and I. Gamstorp. 1958. Paresis and hyperexcitability in adynamia episodica hereditaria. Neurology (Minneapolis) 8: 347–351.
Segura, R. P., and J. H. Petajan. 1979. Neural hyperexcitability in hyperkalemic periodic paralysis. Muscle Nerve 2: 245–249.
Bradley, W. G. 1969. Adynamia episodica hereditaria. Brain 92: 345–378.
Garcin, R., P. Rondot, and M. Fardeau. 1964. Sur les accidents neuromusculaires et en particulier sur une `myopathie vacuolaire’ observés au cours d’un traitement prolongé par la chloroquine: Amélioration rapid apres arrêt due médicament. Rev. Neurol. 111: 117–126.
Bull, G. M., A. B. Carter, and K. G. Lowe. 1953. Hyperpotassaemic paralysis. Lancet 2: 60–63.
Marks, L. J., and E. Feit. 1953. Flaccid quadriplegia, hyperkalemia, and Addison’s disease. Arch. Intern. Med. 91: 56–57.
Richardson, G. O., and J. C. Sibley. 1953. Flaccid quadriplegia associated with hyperpotasseamia. Can. Med. Assoc. J. 69: 504–506.
Mollaret, P., M. Goulon, and M. Tomilhac. 1958. Contribution a l’étude des paralyses avel hyperkaliémie. I. Röle de l’insuffisance cortico-surrénalienne. Rev. Neurol. 98: 341–357.
Pollen, R. H., and R. H. Williams. 1960. Hyperkalemic neuromyopathy in Addison’s disease. N. Engl. J. Med. 263: 273–278.
Faw, M. L., and R. V. Ewer. 1962. Intermittent paralysis and chronic adrenal insufficiency. Ann. Intern. Med. 57: 461–463.
Bell, H., W. L. Hayes, and J. Vosburgh. 1965. Hyperkalemic paralysis due to adrenal insufficiency. Arch. Intern. Med. 115: 418–420.
Daughaday, W. H., and D. Rendleman. 1967. Severe symptomatic hyperkalemia in an adrenalectomized woman due to enhanced mineralocorticoid requirement. Ann. Intern. Med. 66: 1197–1202.
Van Dellen, R. C., and D. C. Purnell. 1969. Hyperkalemic paralysis due to adrenal insufficiency. Mayo Clin. Proc. 44: 904–914.
Vilchez, J. J., A. Cabello, J. Bendito, and T. Villarroya. 1980. Hyperkalemic paralysis neuropathy and persistent motor neuron discharges at rest in Addison’s disease. J. Neurol. Neurosurg. Psychiatry 43: 818–822.
Ucezne, E. O., and B. P. Harrold. 1980. Hyperkalemic paralysis due to spironolactone. Postgrad. Med. J. 56: 256.
Poskanzer, D. C., and D. N. S. Kerr. 1961. A third type of periodic paralysis with normokalemia and favourable response to sodium chloride. Am. J. Med. 31: 328–336.
Meyers, K. R., D. H. Gilden, C. F. Rinaldi, and J. L. Hansen. 1972. Periodic muscle weakness, normokalemia, and tubular aggregates. Neurology (Minneapolis) 22: 269–274.
Tyler, F. H., F. E. Stephens, F. D. Gunn, and G. T. Perkoff. 1951. Studies in disorders of muscle. VII. Clinical manifestations and inheritance of a type of periodic paralysis without hypopotassemia. J. Clin. Invest. 30: 492–502.
Stevens, J. R. 1954. Familial periodic paralysis, myotonia, progressive amyotrophy, and pes cavus in members of a single family. A.M.A. Arch. Neurol. Psychiat. 72: 726–734.
Klein, R. 1963. Periodic paralysis with cardiac arrhythmia. J. Pediatr. 62: 371–376.
Iannoccone, S. T., K. Bove, B. Nagy, and F. J. Samaha. 1982. Familial dystrophy associated with periodic paralysis and a unique deficit of the major protein of sarcoplasmic reticulum. Ann. Neurol. 12: 108–109.
Goldflam, S. 1895. Weitere Mittheilung uber die paroxysmale, familiare Lahmung. Dtsch. Z. Nervenheilkd. 7: 1–12.
Biczyskowa, W., A. Fidzianska, and H. Jedrzejowska. 1969. Light and electron microscopic study of the muscles in hypokalemic periodic paralysis. Acta Neuropathol. 12: 329–346.
Gordon, A. M., J. R. Green, and D. Lagonoff. 1970. Studies on a patient with hypokalemic familial periodic paralysis. Am. J. Med. 48: 185.
Engel, A. G. 1970. Evolution and contents of vacuoles in primary hypokalemic periodic paralysis. Mayo Clin. Proc. 45: 774–814.
Pellissier, J. F., M. C. Faugere, D. Gambarelli, and M. Toba. 1980. Histological, histochemical and ultrastructural studies in five cases. Semin. Hop. Paris 56: 1393–1404.
Norris, F. H., B. J. Panner, and J. M. Stormont. 1968. Thyrotoxic periodic paralysis: Metabolic and ultrastructural studies. Arch. Neurol. 19: 85–98.
Takaci, A., D. L. Schotland, S. DiMauro, and L. P. Rowland. 1973. Thyrotoxic periodic paralysis: Function of SR and muscle glycogen. Neurology (Minneapolis) 23: 100.
Bradley, W. G. 1969. Ultrastructural changes in adynamia episodica hereditaria and normokalemic familial periodic paralysis. Brain 42: 379–390.
Walter, G. F., and L. Auböck. 1980. Case report: Ultrastructural changes of muscles during attacks of adynamia episodic hereditaria. Neuropathol. Appl. Neurobiol. 6: 313–317.
Dyken, M., W. Zeman, and T. Rusche. 1969. Hypokalemic periodic paralysis: Children with permanent myopathic weakness. Neurology (Minneapolis) 19: 691–699.
Wainwright, J., and D. Pirie. 1980. Hypokalemic myopathy. S. Afr. Med. J. 58: 81–84.
Kao, L. I., and A. M. Gordon. 1977. Alteration of skeletal muscle cellular structures by potassium depletion. Neurology (Minneapolis) 27: 855–860.
DeCosta, W. J. P. 1979. Experimental hypokalaemic ultrastructural changes in rat gastrocnemius muscle. Acta Neurol. 45: 79–82.
Corbett, A. J., and M. Pollock. 1981. Experimental potassium depletion myopathy. J. Neurol. Sci. 49: 193–206.
Vastola, E. F., and C. A. Bertrand. 1956. Intracellular water and potassium in periodic paralysis. Neurology (Minneapolis) 6: 523–530.
Conn, J. W., and D. H. Streeten. 1960. Intermittent aldosteronism in periodic paralysis. In: Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, and P. S. Fredrickson, eds. McGraw-Hill, New York. pp. 883–898.
Talso, P. J., M. F. Glenn, Y. T. Oester, and J. Fudema. 1963. Body composition in hypokalemic familial periodic paralysis. Ann. N.Y. Acad. Sci. 110: 994–1001.
Kreindler, A., V. Ionasesco, I. Petrovici, A. Petresco, and G. Calcaianu. 1964. Etudes cliniques et de laboratoire dans la paralysie periodique familiale avec hypokalémie. Rev. Neurol. 110: 377–385.
Niall, J. F., and R. K. Poy. 1966. Studies in familial hypokalemic periodic paralysis. Aust. Ann. Med. 15: 352–356.
Shishiba, Y., K. Shizume, M. Sakuma, H. Yamauchi, K. Nakao, and S. Okinaka. 1966. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. III. Intra-and extra-cellular concentrations of potassium and sodium in muscle and their changes during induced attacks of paralysis. Metabolism 15: 153–162.
Hofmann, W. W., and R. A. Smith. 1970. Hypokalaemic periodic paralysis studied in vitro. Brain 93: 445–474.
Klein, R., T. Egan, and P. Usher. 1960. Changes in sodium, potassium and water in hyperkalemic familial periodic paralysis. Metabolism 9: 1005–1024.
Conn, J. W., S. S. Fajans, L. H. Louis, D. H. P. Streeten, and R. D. Johnson. 1957. Intermittent aldosteronism in periodic paral- ysis: Dependence of attacks on retention of sodium, and failure to induce attacks by restriction of dietary sodium. Lancet 1: 802–805.
Gordon, M. 1978. Periodic familial paralysis with hypokalemia. Hemodynamic and metabolic studies: favorable effect of acetazolamide. Rev. Neurol. 134: 655–672.
Grob, D., R. J. Johns, and Ä. Liljestrand. 1957. Potassium movement in patients with familial periodic paralysis: Relationship to defect in muscle function. Am. J. Med. 23: 356–375.
Sonkodi, S. 1980. Familial periodic paralysis (hypopotassaemic form). Wien. Klin. Wochenschr. 92: 610–613.
Zierler, K. L., and R. Andres. 1957. Movement of potassium into skeletal muscle during spontaneous attack in family periodic paralysis. J. Clin. Invest. 36: 730–737.
Shizume, K., Y. Shishiba, M. Sakuma, H. Yamauchi, K. Nakao, and S. Okinaka. 1966. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. I. Arteriovenous differences of electrolytes during induced paralysis. Metabolism 15: 138–144.
Buruma, O. J., T. M. A. R. Dubbelman, A. W. de Bruyne, and J. van Steveninck. 1978. Erythrocyte membrane studies in familial hypokalemic periodic paralysis. Arch. Neurol. 35: 615–616.
Engel, A. G., C. S. Potter, and J. W. Rosevear. 1967. Studies on carbohydrate metabolism and mitochondrial respiratory activities in primary hypokalemic periodic paralysis. Neurology (Minneapolis) 17: 329–338.
Streeten, D. H. P., and P. J. Speller. 1974. The role of mineralocorticoids in the pathogenesis of hypokalemic periodic paralysis. J. Clin. Endocrinol. Metab. 39: 326–333.
Stearns, R. H., M. Cox, P. U. Feig, and I. Singer. 1984. Internal potassium balance and the control of the plasma potassium concentration. Medicine (Baltimore) 60: 339–354.
Samaha, F. J. 1969. Sodium-potassium adenosine triphosphate in diseased muscle: Studies on periodic paralysis, myasthenia gravis, and Eaton-Lambert syndrome. Neurology (Minneapolis) 19:551–552.
Clausen, T., and J. A. Flatman. 1977. The effect of catecholamines on Na-K transport and membrane potential in rat soleus muscle. J. Physiol. (London) 270: 383–414.
Clausen, T., and P. G. Kohn. 1977. The effect of insulin on the transport of sodium and potassium in rat soleus muscle. J. Physiol. (London) 265: 19–42.
Flatman, J. A., and T. Clausen. 1979. Combined effects of adrenaline and insulin on active electrogenic Na-K transport in rat soleus muscle. Nature (London) 281: 580–581.
Moore, R. D., and J. L. Rabovsky. 1979. Mechanism of insulin action on resting membrane potential of frog skeletal muscle. Am. J. Physiol. 236: C249 - C254.
Erlij, D., and H. F. Schoen. 1981. Effects of insulin on alkali-cation movements across muscle and epithelial cell membranes. Ann. N.Y. Acad. Sci. 372: 272–290.
Clausen, T. 1982. Adrenergic control of Na+-K+ homeostasis. Acta Med. Scand. (Suppl.) 672: 111–115.
Viskoper, R. J., J. Fidel, T. Horn, D. Trivoni, and J. Chaco. 1973. On the beneficial action of acetazolamide in hypokalemic periodic paralysis: Study of carbohydrate metabolism. Am. J. Med. Sci. 226: 125–129.
Vallat, G. 1977. Hypokalemic familial periodic paralysis with basal electrocardiographic changes. Semin. Hop. Paris 53: 1163–1165.
Hofmann, W. W., B. T. Adornato, and H. Reich. 1983. The relationship of insulin receptors to hypokalemic periodic paralysis. Muscle Nerve 6: 48–51.
Shizume, K., Y. Shishiba, M. Sakuma, H. Yamauchi, K. Nakao, and S. Okinaka. 1966. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. II. Total exchangeable sodium and potassium. Metabolism 15: 145–152.
Biron, R., R. Burger, A. Chinet, T. Clausen, and R. DuBoisFerrierer. 1979. Thyroid hormones and the energetics of active sodium-potassium transport in mammalian skeletal muscles. J. Physiol. (London) 297: 47–60.
Sharma, V. K., and S. P. Banerjee. 1978. ß-Adrenergic receptors in rat skeletal muscle: Effects of thyroidectomy. Biochim. Biophys. Acta 539: 538–542.
Smith, E. K. M., and P. D. Samuel. 1970. Abnormalities in the sodium pump of erythryoctes from patients with hypothyroidism. Clin. Sci. 38: 49–61.
Shishiba, Y., T. Shimizu, and T. Saito. 1972. Elevated immunoreactive insulin concentration during spontaneous attacks in thyrotoxic periodic paralysis. Metabolism 21: 285–290.
Offerijns, F. G. J., D. Westerink, and A. F. Willebrands. 1958. The relation of potassium deficiency to muscular paralysis by insulin. J. Physiol. (London) 141: 377–384.
Norgaard, A., K. Kjeldsen, and T. Clausen. 1981. Potassium depletion decreases the number of 3H-ouabain binding sites and the active Na-K transport in skeletal muscle. Nature (London) 293: 739–741.
Erdmann, E., and W. Krawietz. 1977. Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalemia. Acta Biol. Med. Ger. 36: 879–883.
Akaike, N. 1981. Sodium pump in skeletal muscle: Central nervous system-induced suppression by a-adrenoreceptors. Science 213: 1252–1254.
Clausen, T., K. Kjeldsen, and A. Norgaard. 1983. Effects of denervation on sodium, potassium and [3H] ouabain binding in muscles of normal and potassium-depleted rats. J. Physiol. (London) 345: 123–134.
Akaike, N. 1975. Contribution of an electrogenic sodium pump to membrane potential in mammalian skeletal muscle fibers. J. Physiol. (London) 245: 499–520.
Akaike, N. 1978. Resting and action potentials in white muscle of potassium deficient rats. Comp. Biochem. Physiol. 61A: 629–633.
Lewis, E. D., R. C. Griggs, and R. T. Moxley. 1979. Regulation of plasma potassium in hyperkalemic periodic paralysis. Neurology (New York) 29: 1131–1137.
Hoskins, B., T. H. Maren, and F. Q. Vroom. 1974. Acetazolamide and potassium flux in RBC’s-Studies in patients with hyperkalemic periodic paralysis. Arch. Neurol. 31: 187–189.
Clausen, T., P. Wang, H. Orskov, and O. Kristensen. 1980. Hyperkalemic periodic paralysis: Relationships between changes in plasma water, electrolytes, insulin and catecholamine during attacks. Scand. J. Clin. Lab. Invest. 40: 211–220.
Streeten, D. H. P., T. G. Dalakos, and H. Fellerman. 1971. Studies on hyperkalemic periodic paralysis: Evidence of changes in plasma number, CL, and induction of paralysis by adrenal glucocorticoids. J. Clin. Invest. 50: 142–155.
Ruff, R. L. 1985. Endocrine myopathies (hyper-and hypofunction of adrenal, thyroid, pituitary, parathyroid glands, and iatrogenic steroid myopathy). In: Myology. B. Q. Banker and A. G. Engel, eds. McGraw-Hill, New York.
Engel, A. G., and E. H. Lambert. 1969. Calcium activation of electrically inexcitable muscle fibers in primary hypokalemic periodic paralysis. Neurology (Minneapolis) 19: 851–858.
Engel, A. G., C. S. Potter, and J. W. Rosevear. 1964. Nucleotides and adenosine monophosphate deaminase activity in muscle in primary hypokalemic periodic paralysis. Nature (London) 292: 670–672.
Au, K. S., and R. T. T. Yeung. 1972. Thyrotoxic periodic paralysis: Periodic variation in the muscle calcium pump activity. Arch. Neurol. 26: 543–548.
DeGrandis, D., A. Fiaschi, E. Tomelleri, and D. Orrico. 1978. Hypokalemic periodic paralysis: A single fiber electromyographic study. J. Neurol. Sci. 37: 107–112.
Brooks, J. E. 1969. Hyperkalemic periodic paralysis. Arch. Neurol. 20: 13–18.
Norris, F. B., Jr. 1962. Unstable membrane potential in human myotonic muscle. Electroencephalogr. Clin. Neurophysiol. 14: 197–201.
Creutzfeldt, O. D., B. C. Abbott, W. M. Fowler, and C. M. Pearson. 1963. Muscle membrane potentials in episodic adynamia. Electroencephalogr. Clin. Neurophysiol. 15: 508–519.
Riecker, G., and H. D. Bolte. 1966. Membranpotentiale eizelner skeletmuskelzellen bein kypkaliamischer periodischer muskelparalyse. Klin. Wochenschr. 44: 804–807.
McComas, A. J., K. Mrozek, and W. G. Bradley. 1968. The nature of the electrophysiological disorder in adynamia episodica. J. Neurol. Neurosurg. Psychiatry 31: 448–452.
Lehmann-Horn, F., R. Rudel, K. Ricker, H. Lorkovic, R. Dengler, and H. C. Hopf. 1983. Two cases of adynamia episodica hereditaria in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve 6: 113–121.
Rudel, R., F. Lehmann-Horn, K. Ricker, and G. Küther. 1984. Hypokalemic periodic paralysis in vitro investigation of muscle fiber membrane parameters. Muscle Nerve 7: 110–120.
Hodgkin, A. L., and A. F. Huxley. 1952. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (London) 117: 500–544.
Almers, W., P. R. Stanfield, and W. Stühmer. 1983. Slow changes in currents through sodium channels in frog muscle membrane. J. Physiol. (London) 339: 253–271.
Almers, W., W. M. Roberts, and R. L. Ruff. 1984. Voltage clamp of rat and human skeletal muscle: Measurements with an improved loose-patch technique. J. Physiol. (London) 347: 751–768.
Roberts, W. M., R. L. Ruff, and W. Almers. 1983. Sodium currents in human muscle under voltage clamp. Soc. Neurosci. Abstr. 9: 1278.
Ruff, R. L., W. Stühmer, and W. Almers. 1982. The effect of glucocorticoid treatment on mammalian muscle excitability. Pfluegers Arch. 395: 132–137.
Ruff, R. L., D. Martyn, and A. M. Gordon. 1982. Glucocorticoid treatment does not alter muscle membrane excitability. Am. J. Physiol. 243: E512 - E521.
Kao, L. I., and A. M. Gordon. 1965. Mechanism of insulin-induced paralysis of muscles from potassium-depleted rats. Science 188: 740.
Gordon, A. M., and L. I. Kao. 1978. Disorders of muscle membranes: The periodic paralyses. In: Physiology of Membrane Disorders. T. E. Andreoli, J. F. Hoffman, and D. D. Fanestil, eds. Plenum Press, New York. pp. 817–829.
Layzer, R. B. 1982. Periodic paralysis and the sodium-potassium pump. Ann. Neurol. 11: 547–552.
Almers, W. 1979. Potassium concentration changes in the transverse tubules of vertebrate skeletal muscle. Fed. Proc. 39: 1527–1532.
Venosa, R. A., and P. Horwicz. 1981. Density and apparent location of the sodium pump in frog sartorius muscle. J. Membr. Biol. 59: 225–232.
Akaike, N. 1982. Hyperpolarization of mammalian skeletal muscle fibers in K-free media. Am. J. Physiol. 242: C12 - C18.
Stanfield, P. R., N. B. Standen, C. A. Leech, and F. M. Ashcroft. 1980. Inward rectification in skeletal muscle fibers. In: Advances in Physiological Science, Volume V. E. Varga, A. Kover, T. Kovacs, and L. Kovacs, eds. Pergamon Press, Elmsford, N.Y. pp. 247–262.
Sestoft, L. 1967. Direct transition from hypo-to hyperkalemic paralysis during potassium treatment of familial periodic paralysis. Dan. Med. Bull. 14: 157–160.
Lehmann-Horn, F., R. Rüdel, R. Dengler, H. Lorkovic, A. Haass, and K. Ricker. 1981. Membrane defects in paramyotonia congenita with and without myotonia in a warm environment. Muscle Nerve 4: 396–406.
Ricker, K., A. Haass, R. Rüdel, R. Böhlen, and H. G. Mertens. 1980. Successful treatment of paramyotonia congenita (Eulen-berg): Muscle stiffness and weakness prevented by tocainide. J. Neurol. Neurosurg. Psychiatry 43: 812–826.
Ricker, K., R. Bohlen, and R. Rohkamm. 1983. Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis. Neurology (Cleveland) 33: 1615–1618.
Osaku, M., and I. Ohtsuki. 1970. Mechanism of muscular paralysis by insulin with special reference to periodic paralysis. Am. J. Physiol. 219: 1173–1182.
Dengler, R., W. W. Hofmann, and R. Rüdel. 1979. Effect of potassium depletion and insulin on resting and stimulated skeletal rat muscle. J. Neurol. Neurosurg. Psychiatry 42: 818–826.
Huang, K. W. 1943. Pa-Ping: Transient stimulating family periodic paralysis. Chin. Med. J. 61: 305–312.
Henderson, E. G. 1974. Strophanthidin sensitive electrogenic mechanisms in frog sartorius muscles exposed to barium. Pfluegers Arch. 350: 81–95.
Campa, J. F., and D. B. Sanders. 1974. Familial hypokalemic periodic paralysis. Local recovery after nerve stimulation. Arch. Neurol. 31: 110–115.
Bezanilla, F., and C. M. Armstrong. 1972. Negative conductance caused by entry of sodium and cesium ions into the potassium channels of squid axon. J. Gen. Physiol. 60: 588–608.
Johnsen, T. 1977. Trial of the prophylactic effect of diazoxide in the treatment of familial periodic hypokalemia. Acta Neurol. Scand. 56: 525–532.
Griggs, R. C., W. K. Engel, and J. S. Resnick. 1970. Acetazolamide treatment of hypokalemic periodic paralysis. Ann. Intern. Med. 73: 39–48.
Viskoper, R. J., A. Licht, J. Fidel, and J. Chaco. 1973. On the beneficial action of acetazolamide treatment in hypokalemic periodic paralysis: A metabolic and electromyographic study. Am. J. Med. Sci. 266: 119–123.
Johnsen, T. 1977. Effect upon serum insulin, glucose and potassium concentrations of acetazolamide during attacks of familial periodic paralysis. Acta Neurol. Scand. 56: 533–541.
Gerard, J. M. 1979. Familial periodic paralysis with hypokalemia, hyperaldosteronism, and extracellular vacuolization. Rev. Neurol. 134: 761–772.
Riggs, J. E., R. C. Griggs, and R. T. Moxley. 1984. Dissociation of glucose and potassium arterial-venous differences across the forearm by acetazolamide. Arch. Neurol. 41: 35–38.
Campbell, D. T., and B. Hille. 1976. Kinetic and pharmacological properties of the sodium channel of frog skeletal muscle. J. Gen. Physiol. 67: 309–323.
Conway, M. J., J. A. Seibel, and R. P. Eaton. 1974. Thyrotoxicosis and periodic paralysis improvement with beta blockade. Ann. Intern. Med. 81: 332–336.
Yeung, R. T. F., and T. F. Tse. 1974. Thyrotoxic periodic paralysis: Effect of propranolol. Am. J. Med. 57: 584–590.
Resnick, J. 1969. Thyrotoxic periodic paralysis. Am. J. Med. 47: 831–838.
Riggs, J. E., R. C. Griggs, R. T. Moxley, and E. D. Lewis. 1981. Acute effects of acetazolamide in hyperkalemic periodic paralysis. Neurology (New York) 31: 725–729.
Hoskins, B. 1977. Studies on the mechanism of action of acetazolamide in the prophylaxis of hyperkalemic periodic paralysis. Life Sci. 20: 343–350.
Wang, P., and T. Clausen. 1975. Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet 1: 221–223.
Wang, P., T. Clausen, and H. Oerskov. 1978. Salbutamol inhalations suppress attacks of hyperkalemia in familial periodic paralysis. Monogr. Hum. Genet. 10: 62–65.
Dahl-Jorgensen, K., and H. Michalsen. 1979. Adynamia episodica herediteria: Treatment with salbutamol. Acta Paediatr. Scand. 68: 583–585.
Adrian, R. H., and W. H. Freygang. 1962. Potassium conductance of frog muscle membrane under controlled voltage. J. Physiol. (London) 163: 104–138.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Publishing Corporation
About this chapter
Cite this chapter
Ruff, R.L., Gordon, A.M. (1987). Disorders of Muscle. In: Andreoli, T.E., Hoffman, J.F., Fanestil, D.D., Schultz, S.G. (eds) Clinical Disorders of Membrane Transport Processes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1286-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1286-4_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-42699-5
Online ISBN: 978-1-4684-1286-4
eBook Packages: Springer Book Archive